RecallDepth
Class II Ongoing

Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-452-17

This recall is currently active, issued July 23, 2025. It was issued by Accord Healthcare, Inc..

Company
Accord Healthcare, Inc.
Recall Initiated
June 20, 2025
Posted
July 23, 2025
Recall Number
D-0522-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
4,896 bottles
Firm Location
Raleigh, NC, United States
Official Source
View on FDA website ↗

Reason for Recall

Subpotent Drug: Assay below the approved specification

Distribution

Nationwide in the USA

Lot / Code Info

Lot #D2300104, Exp Date: 12/31/2025

More recalls by Accord Healthcare, Inc.

View all recalls by this company →

Other recent Class II Drug recalls